GPAS
EIT Pathogena is dedicated to revolutionising infectious disease prevention and treatment through data-driven, global pathogen monitoring systems. It aims to build an 'Always-On' pathogen detection ecosystem, leveraging advanced genomics, AI, and international collaboration to improve health outcomes worldwide. The company develops cloud-based bioinformatics platforms for rapid, accurate pathogen genome analysis, supporting public health, research, and clinical applications.
Industries
Nr. of Employees
small (1-50)
Products
Bioinformatics Analysis Platform
A cloud-hosted, automated platform for pathogen sequence assembly, variant calling, species/lineage identification, resistance prediction, and report generation; supports web portal and CLI uploads.
SARS-CoV-2 genomic analysis pipeline
Amplicon-aware pipeline for tiled-amplicon SARS-CoV-2 sequencing that produces consensus assemblies, lineage assignments, related-isolate detection, and automated reports; validated across multiple sites and thousands of genomes.
Mycobacterium (TB & NTM) genomic analysis pipeline
Automated whole-genome sequencing pipeline for Mycobacterium tuberculosis complex and non-tuberculous mycobacteria including species identification, lineage calling, related-isolate detection and resistance prediction for multiple drugs.
Bioinformatics Analysis Platform
A cloud-hosted, automated platform for pathogen sequence assembly, variant calling, species/lineage identification, resistance prediction, and report generation; supports web portal and CLI uploads.
SARS-CoV-2 genomic analysis pipeline
Amplicon-aware pipeline for tiled-amplicon SARS-CoV-2 sequencing that produces consensus assemblies, lineage assignments, related-isolate detection, and automated reports; validated across multiple sites and thousands of genomes.
Mycobacterium (TB & NTM) genomic analysis pipeline
Automated whole-genome sequencing pipeline for Mycobacterium tuberculosis complex and non-tuberculous mycobacteria including species identification, lineage calling, related-isolate detection and resistance prediction for multiple drugs.
Services
Scalable SaaS platform for assembly, variant calling, species and lineage identification, resistance prediction, and automated reporting for pathogen genomic data.
Account setup, role management (standard and super users), and opt-in inter-organisation secure data sharing and collaboration configuration.
Options to remove human reads via a command-line tool prior to upload or automatic human read removal on upload to the portal to reduce PII risk.
Built-in portal support features, troubleshooting guides, and email support for technical issues and onboarding.
Collaborative partnerships and network agreements for secure, de-identified pathogen data sharing to enable surveillance, research, and public health responses.
Scalable SaaS platform for assembly, variant calling, species and lineage identification, resistance prediction, and automated reporting for pathogen genomic data.
Account setup, role management (standard and super users), and opt-in inter-organisation secure data sharing and collaboration configuration.
Options to remove human reads via a command-line tool prior to upload or automatic human read removal on upload to the portal to reduce PII risk.
Built-in portal support features, troubleshooting guides, and email support for technical issues and onboarding.
Collaborative partnerships and network agreements for secure, de-identified pathogen data sharing to enable surveillance, research, and public health responses.
Expertise Areas
- Pathogen genomics analysis
- Bioinformatics pipeline development
- Genomic surveillance and outbreak detection
- Antimicrobial resistance prediction
Key Technologies
- Next-generation sequencing (short- and long-read FASTQ inputs)
- Tiled-amplicon sequencing
- Consensus genome assembly
- Lineage assignment algorithms
News & Updates
EIT Pathogena Launches SARS-CoV-2 Genomic Analysis Pipeline
Unveiled at the Festival of Genomics and Biodata, this new platform supports real-time genomic analysis of SARS-CoV-2.
EIT Pathogena at ESCMID Global 2025
Participation in the conference to showcase innovations in infectious disease genomics.
Festival of Genomics & Biodata 2025
Participation and product launch at the event emphasizing the power of pathogen genomics.
Details the performance and validation of EIT Pathogena's SARS-CoV-2 analysis pipeline across multiple global sites.
Discusses the 'Always-On' approach to pathogen surveillance and its implications.
Explores the impact of genome sequencing on microbiology diagnostics.
EIT Pathogena Launches SARS-CoV-2 Genomic Analysis Pipeline
Unveiled at the Festival of Genomics and Biodata, this new platform supports real-time genomic analysis of SARS-CoV-2.
EIT Pathogena at ESCMID Global 2025
Participation in the conference to showcase innovations in infectious disease genomics.
Festival of Genomics & Biodata 2025
Participation and product launch at the event emphasizing the power of pathogen genomics.
Details the performance and validation of EIT Pathogena's SARS-CoV-2 analysis pipeline across multiple global sites.
Discusses the 'Always-On' approach to pathogen surveillance and its implications.
Explores the impact of genome sequencing on microbiology diagnostics.